A Study to Evaluate Reiki Therapy as an Intervention in Hematology/Oncology Cancer Patients Hospitalized in an Inpatient Setting

Overview

About this study

The primary purpose of this study is to evaluate the feasibility of offering and providing Reiki Therapy in hospitalized hematology/oncology cancer patients.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria:

  • Hospitalized hematology-oncology patients, age 18 – 80 years old.
  • Able to speak English and complete surveys.
  • Able to read, understand and sign inform consent.

 Exclusion Criteria: 

  • Patient unwilling for reiki therapy.
  • Unable to give written consent.
  • Already having received or receiving other reiki treatment.
  • Pregnant women. (as verbalized by participant)/

 

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Brent Bauer, M.D.

Open for enrollment

Contact information:

Susanne Cutshall APRN, CNS, D.N.P.

(507)293-3226

cutshall.susanne@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20461419

Mayo Clinic Footer